B. Rademaker

621 total citations
22 papers, 533 citations indexed

About

B. Rademaker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, B. Rademaker has authored 22 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in B. Rademaker's work include Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Hormonal and reproductive studies (3 papers). B. Rademaker is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Neuroscience and Neuropharmacology Research (4 papers) and Hormonal and reproductive studies (3 papers). B. Rademaker collaborates with scholars based in Netherlands. B. Rademaker's co-authors include Aalt Bast, J.H.H. Thijssen, F. Schwarz, Albert van der Vliet, Klaas Kramer, G R Westerhof, Gerrit Jansen, Jan H. Schornagel, Ietje Kathmann and Gert Rijksen and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

B. Rademaker

22 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Rademaker Netherlands 12 289 115 110 94 87 22 533
M A Bayne United States 8 275 1.0× 129 1.1× 46 0.4× 14 0.1× 84 1.0× 11 782
Edwin A. Kroeger Canada 14 225 0.8× 150 1.3× 51 0.5× 12 0.1× 44 0.5× 22 570
Katsuo Ikezawa Japan 15 249 0.9× 227 2.0× 120 1.1× 17 0.2× 66 0.8× 47 585
Chieko Kurono Japan 15 376 1.3× 110 1.0× 52 0.5× 29 0.3× 64 0.7× 30 663
Phillip J. Gardiner United Kingdom 19 365 1.3× 873 7.6× 225 2.0× 23 0.2× 226 2.6× 40 1.3k
Shuang Luo China 9 231 0.8× 370 3.2× 60 0.5× 23 0.2× 24 0.3× 13 909
Junji Takada Japan 12 190 0.7× 330 2.9× 37 0.3× 32 0.3× 106 1.2× 20 709
Takaharu Maruyama Japan 6 407 1.4× 125 1.1× 30 0.3× 10 0.1× 87 1.0× 7 1.1k
Georgette Howard United States 16 543 1.9× 91 0.8× 27 0.2× 15 0.2× 93 1.1× 25 863
Morris L. Givner Canada 14 263 0.9× 37 0.3× 23 0.2× 18 0.2× 24 0.3× 49 673

Countries citing papers authored by B. Rademaker

Since Specialization
Citations

This map shows the geographic impact of B. Rademaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Rademaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Rademaker more than expected).

Fields of papers citing papers by B. Rademaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Rademaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Rademaker. The network helps show where B. Rademaker may publish in the future.

Co-authorship network of co-authors of B. Rademaker

This figure shows the co-authorship network connecting the top 25 collaborators of B. Rademaker. A scholar is included among the top collaborators of B. Rademaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Rademaker. B. Rademaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Frank, Hans‐Peter Voss, Harry W.M. Steinbusch, et al.. (1994). Characterization of the binding of the first selective radiolabeled histamine H3‐receptor antagonist, [125I]‐iodophenpropit, to rat brain. British Journal of Pharmacology. 113(2). 355–362. 47 indexed citations
2.
Jansen, Frank, B. Rademaker, Aalt Bast, & H. Timmerman. (1992). The first radiolabeled histamine H3 receptor antagonist, [125I]iodophenpropit: Saturable and reversible binding to rat cortex membranes. European Journal of Pharmacology. 217(2-3). 203–205. 34 indexed citations
3.
Vliet, Albert van der, et al.. (1992). Role of the epithelium in the control of intestinal motility: Implications for intestinal damage after anoxia and reoxygenation. Inflammation Research. 36(1-2). 159–167. 7 indexed citations
4.
Vliet, Albert van der, B. Rademaker, & Aalt Bast. (1990). A beta adrenoceptor with atypical characteristics is involved in the relaxation of the rat small intestine.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 218–226. 53 indexed citations
5.
Rademaker, B., Klaas Kramer, Aalt Bast, & H. Timmerman. (1990). Evidence for cell type dependent mechanisms in agonist-induced down-regulation of beta-adrenoceptors.. PubMed. 67(3). 321–36. 2 indexed citations
6.
Vliet, Albert van der, et al.. (1990). Intestinal motility disorder induced by peroxides: possible role of lipid peroxidation.. PubMed. 70(2). 227–43. 12 indexed citations
7.
Jansen, Gerrit, G R Westerhof, Ietje Kathmann, et al.. (1989). Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.. PubMed. 49(9). 2455–9. 63 indexed citations
8.
Jansen, Gerrit, Ietje Kathmann, B. Rademaker, et al.. (1989). Expression of a folate binding protein in L1210 cells grown in low folate medium.. PubMed. 49(8). 1959–63. 68 indexed citations
9.
Kelder, Gabriëlle M. Donné-Op den, et al.. (1988). Mapping of the .beta.2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states. Journal of Medicinal Chemistry. 31(6). 1069–1079. 8 indexed citations
10.
Jansen, Gerrit, et al.. (1988). Expression of a membrane folate binding protein in human leukemic ccrf cem cells resistant to methotrexate by virtue of impaired transport. 29. 303. 1 indexed citations
11.
Rademaker, B., Klaas Kramer, Aalt Bast, & H. Timmerman. (1988). Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites.. PubMed. 60(2). 147–59. 6 indexed citations
12.
Haaksma, Eric, et al.. (1987). Studies on the active molecular species of the H2-receptor antagonists cimetidine and mifentidine. Journal of Medicinal Chemistry. 30(1). 208–211. 6 indexed citations
13.
Leurs, Rob, B. Rademaker, Klaas Kramer, H. Timmerman, & Aalt Bast. (1986). The effects of 4-hydroxy-2,3-trans-nonenal on β-adrenoceptors of rat lung membranes. Chemico-Biological Interactions. 59(2). 211–218. 16 indexed citations
14.
Sterk, Geert Jan, et al.. (1986). Histamine H2-binding on guinea pig cerebral cortex. Inflammation Research. 18(1-2). 231–234. 18 indexed citations
15.
Dzoljic, M.R., et al.. (1986). Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.. PubMed. 283(2). 222–8. 14 indexed citations
16.
Rademaker, B., et al.. (1985). Non-Specific Binding of the Fluorescent B-Adrenergic Receptor Probe Alprenolol-NBD. Journal of Receptor Research. 5(2-3). 121–131. 8 indexed citations
17.
Rademaker, B., et al.. (1985). High affinity non-β-adrenoceptor binding of β-adrenergic ligands. European Journal of Pharmacology. 111(1). 31–36. 22 indexed citations
18.
Rademaker, B., et al.. (1980). Metabolism of estradiol-17β, 5-androstene-3β,17β-diol and testosterone in human breast cancer cells in long-term culture. Journal of Steroid Biochemistry. 13(7). 787–791. 6 indexed citations
19.
Rademaker, B., et al.. (1976). A semiautomated method for the determination of 11-deoxy-17-oxo-steroids in urine. Clinica Chimica Acta. 70(3). 349–356. 4 indexed citations
20.
Thijssen, J.H.H., et al.. (1975). The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity. Contraception. 11(1). 53–59. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026